ALTER TABLE "t_report_survey"
ADD COLUMN IF NOT EXISTS  tracked_changes_url character varying(512) DEFAULT '';

ALTER TABLE "t_report_survey" 
RENAME COLUMN "q30" TO "q30_details";

ALTER TABLE "t_report_survey"
ADD COLUMN IF NOT EXISTS  q30 character varying(512) DEFAULT '';

DELETE FROM "mail_templates" 
WHERE  hashtag IN 
('#ReminderReviewerReviewInvitationNewUserStage2','#DefaultReviewInvitationRegisteredUserNewReviewerStage2', '#DefaultReviewInvitationRegisteredUserReturningReviewerStage2', '#DefaultReviewInvitationNewUserStage2', '#ReminderReviewInvitationRegisteredUserNewReviewerStage2', '#ReminderReviewInvitationRegisteredUserReturningReviewerStage2');

INSERT INTO "mail_templates"("hashtag","lang","subject","description","contents")
VALUES
(E'#DefaultReviewInvitationRegisteredUserNewReviewerStage2',E'default',E'{{appName}}: Invitation to review a report',E'Invitation to a registered user who did NOT review the Stage 1 manuscript to review the corresponding Stage 2 submission',E'<p><span style="font-weight: 400;">Dear {{destPerson}},</span></p>\n<p><span style="font-weight: 400;">A Stage 2 Registered Report entitled "{{articleTitle}}", has been submitted for potential recommendation by {{description}} (PCI RR) and I am writing to ask if you would kindly consider reviewing it for us. A clean version of the manuscript can be viewed and downloaded at the following address: <a href="{{art_doi}}">{{art_doi}}</a></span></p>\n<p><span style="font-weight: 400;">As you may know, PCI RR is a free, non-commercial platform dedicated to the peer review of RR preprints. Once a preprint is reviewed and positively recommended by PCI RR, authors then have the option to submit their manuscript to a traditional journal, and the reviews are published on the PCI RR website. A growing</span><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Frr.peercommunityin.org%2Fabout%2Fpci_rr_friendly_journals&amp;data=04%7C01%7Cchambersc1%40cardiff.ac.uk%7C3b0bd2172d19499a650008d934ba39af%7Cbdb74b3095684856bdbf06759778fcbc%7C1%7C0%7C637598796701743675%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=JXBq1vVpf1%2FrbMY0RB9K55orGA%2ByyWDd7mduvA7qQvc%3D&amp;reserved=0"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">list of PCI RR-friendly journals</span></a><span style="font-weight: 400;"> now immediately accept submissions recommended by PCI RR without further peer review.</span></p>\n<p><span style="font-weight: 400;">The above manuscript previously received Stage 1 in-principle acceptance and is now being considered at Stage 2, which includes the content from Stage 1 plus the results and conclusions. Even though you were not a reviewer at Stage 1, I am writing to ask if you would consider evaluating the Stage 2 manuscript for us.&nbsp;</span></p>\n<p>&nbsp;</p>\n<p><span style="font-weight: 400;">At Stage 2 we ask reviewers to assess:</span></p>\n<p><span style="font-weight: 400;">2A. Whether the data are able to test the authors’ proposed hypotheses (or answer the proposed research question) by passing the approved outcome-neutral criteria, such as absence of floor and ceiling effects or success of positive controls or other quality checks.</span></p>\n<p><span style="font-weight: 400;">2B. Whether the introduction, rationale and stated hypotheses (where applicable) are the same as the approved Stage 1 submission. This can be readily assessed by referring to the </span><a href="{{Stage2vsStage1_trackedchangesURL}}"><strong>tracked-changes manuscript supplied by the authors</strong></a><span style="font-weight: 400;"><a href="{{Stage2vsStage1_trackedchangesURL}}">.</a> </span></p>\n<p><span style="font-weight: 400;">{{Stage2_Stage1recommendationtext}}</span></p>\n<p><span style="font-weight: 400;">2C. Whether the authors adhered precisely to the registered study procedures. For reference, the registered Stage 1 manuscript, unchanged from the point of in-principle acceptance, may be downloaded </span><a href="{{Stage1_registeredURL}}"><strong>here</strong></a><span style="font-weight: 400;">.</span></p>\n<p><span style="font-weight: 400;">2D. Where applicable, whether any unregistered exploratory analyses are justified, methodologically sound, and informative.</span></p>\n<p><span style="font-weight: 400;">2E. Whether the authors’ conclusions are justified given the evidence.</span></p>\n<p><span style="font-weight: 400;">The PCI RR website includes an</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_6720026472751613309075757"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">expanded description of these review criteria</span></a><span style="font-weight: 400;">, additional</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_7586915642301613635089357"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">tips for reviewing a RR</span></a><span style="font-weight: 400;">, and</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">complete reviewer guidelines</span></a><span style="font-weight: 400;">. To ensure swift handling of submissions, the requested review time is </span><strong>{{reviewDuration}}</strong><span style="font-weight: 400;">, but if you are unable to review the manuscript within this time then please let me know by reply email and we can extend the timeframe.&nbsp;</span></p>\n<p><span style="font-weight: 400;">Please note that the statistical significance, novelty, or perceived importance of findings will not factor into editorial decisions.</span></p>\n<p><span style="font-weight: 400;">{{signedreview_invitation_text}}&nbsp;</span></p>\n<p><span style="font-weight: 400;">In the event of a favourable outcome, all editorial correspondence (Stage 2 reviews, recommender’s decisions, authors’ replies) and a recommendation text will be published by PCI RR under a CC-BY 4.0 license. If, after one or several rounds of review, the Stage 2 manuscript is rejected, the editorial correspondence (and specifically your Stage 2 review) will NOT be published. You will be notified by e-mail at each stage in the procedure.</span></p>\n<p><span style="font-weight: 400;">{{programmaticRR_invitation_text}}</span></p>\n<p><span style="font-weight: 400;">Note that to avoid any conflict of interests, where you know the identity of the submitting authors you should not accept to evaluate this submission if the authors are close colleagues (people belonging to the same laboratory/unit/department in the last four years, people with whom you have published in the last four years, with whom you have received joint funding in the last four years, or with whom you are currently writing a manuscript, or submitting a grant proposal).</span></p>\n<p><span style="font-weight: 400;">I would be grateful if you could let me know as soon as possible whether you are willing to accept my invitation to review this article, or whether you would prefer to decline, by clicking on the link below or by logging onto the PCI RR website and going to \'For contributors —&gt; Invitation(s) to review a preprint\' in the top menu. If you are reviewing a revised manuscript, you will find the authors\' response to reviewers linked on the website.</span></p>\n<p><span style="font-weight: 400;">Many thanks for considering this review request.</span></p>\n<p><span style="font-weight: 400;">Best wishes,</span></p>\n<p><span style="font-weight: 400;">{{sender}} and the PCI RR Managing Board</span></p>'),
(E'#DefaultReviewInvitationRegisteredUserReturningReviewerStage2',E'default',E'{{appName}}: Invitation to review a report',E'Invitation to a registered user who reviewed a Stage 1 manuscript to review the corresponding Stage 2 submission',E'<p><span style="font-weight: 400;">Dear {{destPerson}},</span></p>\n<p><span style="font-weight: 400;">Thank you for reviewing previously for Peer Community in Registered Reports (PCI RR).</span></p>\n<p><span style="font-weight: 400;">Following in-principle acceptance (IPA) of the Stage 1 submission that you reviewed, the authors have submitted a follow-up Stage 2 manuscript entitled "</span><strong>{{art_title}}</strong><span style="font-weight: 400;">". The Stage 2 manuscript contains the content from Stage 1 plus the results and conclusions, and I am writing to ask if you would kindly consider reviewing it for us. A clean version of the Stage 2 manuscript can be viewed and downloaded at the following address: <a href="{{art_doi}}">{{art_doi}}</a></span></p>\n<p><span style="font-weight: 400;">{{signedreview_invitation_text}}&nbsp;</span></p>\n<p><span style="font-weight: 400;">For reference, the registered Stage 1 manuscript, unchanged from the point of IPA, may be downloaded </span><a title="here" href="{{Stage1_registeredURL}}"><strong>here</strong></a><span style="font-weight: 400;">. To make the review process as easy as possible, a tracked-changes version of the Stage 2 manuscript is also available </span><a title="here" href="{{Stage2vsStage1_trackedchangesURL}}"><strong>here</strong></a><span style="font-weight: 400;"> that shows all text changes between the approved Stage 1 manuscript and the corresponding sections of the Stage 2 manuscript. </span></p>\n<p><span style="font-weight: 400;">{{Stage2_Stage1recommendationtext}}</span></p>\n<p><span style="font-weight: 400;">{{programmaticRR_invitation_text}}<br></span></p>\n<p><span style="font-weight: 400;">In evaluating Stage 2 manuscripts, we ask reviewers to assess:</span></p>\n<p><span style="font-weight: 400;">2A. Whether the data are able to test the authors’ proposed hypotheses (or answer the proposed research question) by passing the approved outcome-neutral criteria, such as absence of floor and ceiling effects or success of positive controls or other quality checks.</span></p>\n<p><span style="font-weight: 400;">2B. Whether the introduction, rationale and stated hypotheses (where applicable) are the same as the approved Stage 1 submission. This can be readily assessed by referring to the </span><a title="tracked-changes manuscript supplied by the authors" href="{{Stage2vsStage1_trackedchangesURL}}"><strong>tracked-changes manuscript supplied by the authors</strong><span style="font-weight: 400;">.</span></a></p>\n<p><span style="font-weight: 400;">2C. Whether the authors adhered precisely to the registered study procedures.</span></p>\n<p><span style="font-weight: 400;">2D. Where applicable, whether any unregistered exploratory analyses are justified, methodologically sound, and informative.</span></p>\n<p><span style="font-weight: 400;">2E. Whether the authors’ conclusions are justified given the evidence.</span></p>\n<p><span style="font-weight: 400;">The PCI RR website includes an</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_6720026472751613309075757"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">expanded description of these review criteria</span></a><span style="font-weight: 400;">, additional</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_7586915642301613635089357"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">tips for reviewing a RR</span></a><span style="font-weight: 400;">, and</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">complete reviewer guidelines</span></a><span style="font-weight: 400;">. To ensure swift handling of submissions, the requested review time is </span><strong>{{reviewDuration}}</strong><span style="font-weight: 400;">, but if you are unable to review the manuscript within this time then please let me know by reply email and we can extend the timeframe. Where possible, it is important that the same reviewers evaluate submissions at Stage 1 and Stage 2.</span></p>\n<p><span style="font-weight: 400;">Please note that the statistical significance, novelty, or perceived importance of findings will not factor into editorial decisions.</span></p>\n<p><span style="font-weight: 400;">In the event of a favourable outcome, all editorial correspondence (Stage 2 reviews, recommender’s decisions, authors’ replies) and a recommendation text will be published by PCI RR under a CC-BY 4.0 license. If, after one or several rounds of review, the Stage 2 manuscript is rejected, the editorial correspondence (and specifically your Stage 2 review) will NOT be published. You will be notified by e-mail at each stage in the procedure.</span></p>\n<p><span style="font-weight: 400;">Note that to avoid any conflict of interests, where you know the identity of the submitting authors you should not accept to evaluate this submission if the authors are close colleagues (people belonging to the same laboratory/unit/department in the last four years, people with whom you have published in the last four years, with whom you have received joint funding in the last four years, or with whom you are currently writing a manuscript, or submitting a grant proposal).</span></p>\n<p><span style="font-weight: 400;">Please let me know as soon as possible whether you are willing to accept my invitation to review this article, or whether you would prefer to decline, by clicking on the link below or by logging onto the {{longname}} website and going to \'For contributors —&gt; Invitation(s) to review a preprint\' in the top menu.</span></p>\n<p><span style="font-weight: 400;">Many thanks for considering this re-review request and for helping to support PCI RR.</span></p>\n<p><span style="font-weight: 400;">Best wishes,</span></p>\n<p><span style="font-weight: 400;">{{sender}} and the PCI RR Managing Board</span></p>\n<p>&nbsp;</p>'),
(E'#DefaultReviewInvitationNewUserStage2',E'default',E'{{appName}}: Invitation to review a report',E'Invitation to a new user who did NOT review the Stage 1 manuscript to review the corresponding Stage 2 submission',E'<p><span style="font-weight: 400;">Dear {{destPerson}},</span></p>\n<p><span style="font-weight: 400;">A Stage 2 Registered Report entitled "{{articleTitle}}", has been submitted for potential recommendation by {{description}} (PCI RR) and I am writing to ask if you would kindly consider reviewing it for us. A clean version of the manuscript can be viewed and downloaded at the following address: <a href="{{art_doi}}">{{art_doi}}</a></span></p>\n<p><span style="font-weight: 400;">As you may know, Registered Reports (RRs) are a form of empirical research article in which manuscripts containing a study proposal are reviewed prior to data collection or analysis. The aim of this initiative is to minimise publication bias and reporting bias, while also allowing the flexibility to conduct exploratory (unregistered) analyses and report serendipitous findings. Submitted manuscripts can propose novel studies or direct replications of previous studies.</span></p>\n<p><span style="font-weight: 400;">PCI RR is a free, non-commercial platform dedicated to the peer review of RR preprints. Once a preprint is reviewed and positively recommended by PCI RR, authors then have the option to submit their manuscript to a traditional journal, and the reviews are published on the PCI RR website. A growing</span><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Frr.peercommunityin.org%2Fabout%2Fpci_rr_friendly_journals&amp;data=04%7C01%7Cchambersc1%40cardiff.ac.uk%7C3b0bd2172d19499a650008d934ba39af%7Cbdb74b3095684856bdbf06759778fcbc%7C1%7C0%7C637598796701743675%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=JXBq1vVpf1%2FrbMY0RB9K55orGA%2ByyWDd7mduvA7qQvc%3D&amp;reserved=0"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">list of PCI RR-friendly journals</span></a><span style="font-weight: 400;"> now immediately accept submissions recommended by PCI RR without further peer review.</span></p>\n<p><span style="font-weight: 400;">The above manuscript previously received Stage 1 in-principle acceptance and is now being considered at Stage 2, which includes the content from Stage 1 plus the results and conclusions. Even though you were not a reviewer at Stage 1, I am writing to ask if you would consider evaluating the Stage 2 manuscript for us.&nbsp;</span></p>\n<p>&nbsp;</p>\n<p><span style="font-weight: 400;">At Stage 2 we ask reviewers to assess:</span></p>\n<p><span style="font-weight: 400;">2A. Whether the data are able to test the authors’ proposed hypotheses (or answer the proposed research question) by passing the approved outcome-neutral criteria, such as absence of floor and ceiling effects or success of positive controls or other quality checks.</span></p>\n<p><span style="font-weight: 400;">2B. Whether the introduction, rationale and stated hypotheses (where applicable) are the same as the approved Stage 1 submission. This can be readily assessed by referring to the </span><a href="{{Stage2vsStage1_trackedchangesURL}}"><strong>tracked-changes manuscript supplied by the authors</strong><span style="font-weight: 400;">. </span></a></p>\n<p><span style="font-weight: 400;">{{Stage2_Stage1recommendationtext}}</span></p>\n<p><span style="font-weight: 400;">2C. Whether the authors adhered precisely to the registered study procedures. For reference, the registered Stage 1 manuscript, unchanged from the point of in-principle acceptance, may be downloaded </span><a href="{{Stage1_registeredURL}}"><strong>here</strong><span style="font-weight: 400;">.</span></a></p>\n<p><span style="font-weight: 400;">2D. Where applicable, whether any unregistered exploratory analyses are justified, methodologically sound, and informative.</span></p>\n<p><span style="font-weight: 400;">2E. Whether the authors’ conclusions are justified given the evidence.</span></p>\n<p><span style="font-weight: 400;">The PCI RR website includes an</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_6720026472751613309075757"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">expanded description of these review criteria</span></a><span style="font-weight: 400;">, additional</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_7586915642301613635089357"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">tips for reviewing a RR</span></a><span style="font-weight: 400;">, and</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">complete reviewer guidelines</span></a><span style="font-weight: 400;">. To ensure swift handling of submissions, the requested review time is </span><strong>{{reviewDuration}}</strong><span style="font-weight: 400;">, but if you are unable to review the manuscript within this time then please let me know by reply email and we can extend the timeframe.&nbsp;</span></p>\n<p><span style="font-weight: 400;">Please note that the statistical significance, novelty, or perceived importance of findings will not factor into editorial decisions.</span></p>\n<p><span style="font-weight: 400;">{{signedreview_invitation_text}}&nbsp;</span></p>\n<p><span style="font-weight: 400;">In the event of a favourable outcome, all editorial correspondence (Stage 2 reviews, recommender’s decisions, authors’ replies) and a recommendation text will be published by PCI RR under a CC-BY 4.0 license. If, after one or several rounds of review, the Stage 2 manuscript is rejected, the editorial correspondence (and specifically your Stage 2 review) will NOT be published. You will be notified by e-mail at each stage in the procedure.</span></p>\n<p><span style="font-weight: 400;">{{programmaticRR_invitation_text}}</span></p>\n<p><span style="font-weight: 400;">Note that to avoid any conflict of interests, where you know the identity of the submitting authors you should not accept to evaluate this submission if the authors are close colleagues (people belonging to the same laboratory/unit/department in the last four years, people with whom you have published in the last four years, with whom you have received joint funding in the last four years, or with whom you are currently writing a manuscript, or submitting a grant proposal).</span></p>\n<p><span style="font-weight: 400;">I would be most grateful if you could let me know using the link below whether you are willing to accept our invitation to review this article, or whether you would prefer to decline. If you accept the assignment then once you have entered a new password and logged onto the website, please go to \'For contributors —&gt; Invitation(s) to review a report\' in the top menu. If you are reviewing a revised manuscript, you will find the authors\' response to reviewers linked on the website.</span></p>\n<p><span style="font-weight: 400;">Many thanks for considering this review request.</span></p>\n<p><span style="font-weight: 400;">Best wishes,</span></p>\n<p><span style="font-weight: 400;">{{sender}} and the PCI RR Managing Board</span></p>'),
(E'#ReminderReviewInvitationRegisteredUserNewReviewerStage2',E'default',E'{{appName}}: Invitation to review a Stage 2 manuscript - reminder',E'Reminder invitation to a registered user who did NOT review the Stage 1 manuscript to review the corresponding Stage 2 submission',E'<div><span style="font-weight: 400;">Dear {{destPerson}},</span></div><div>&nbsp;</div><div>This is a kind reminder about the review invitation below.</div><div>&nbsp;</div><div><span style="font-weight: 400;">A Stage 2 Registered Report entitled "<strong>{{articleTitle}}</strong>", has been submitted for potential recommendation by {{description}} (PCI RR) and I am writing to ask if you would kindly consider reviewing it for us. A clean version of the manuscript can be viewed and downloaded at the following address: <a href="{{art_doi}}">{{art_doi}}</a></span></div><div>&nbsp;</div><div><span style="font-weight: 400;">As you may know, PCI RR is a free, non-commercial platform dedicated to the peer review of RR preprints. Once a preprint is reviewed and positively recommended by PCI RR, authors then have the option to submit their manuscript to a traditional journal, and the reviews are published on the PCI RR website. A growing</span><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Frr.peercommunityin.org%2Fabout%2Fpci_rr_friendly_journals&amp;data=04%7C01%7Cchambersc1%40cardiff.ac.uk%7C3b0bd2172d19499a650008d934ba39af%7Cbdb74b3095684856bdbf06759778fcbc%7C1%7C0%7C637598796701743675%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=JXBq1vVpf1%2FrbMY0RB9K55orGA%2ByyWDd7mduvA7qQvc%3D&amp;reserved=0"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">list of PCI RR-friendly journals</span></a><span style="font-weight: 400;"> now immediately accept submissions recommended by PCI RR without further peer review.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">The above manuscript previously received Stage 1 in-principle acceptance and is now being considered at Stage 2, which includes the content from Stage 1 plus the results and conclusions. Even though you were not a reviewer at Stage 1, I am writing to ask if you would consider evaluating the Stage 2 manuscript for us.&nbsp;</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">At Stage 2 we ask reviewers to assess:</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2A. Whether the data are able to test the authors’ proposed hypotheses (or answer the proposed research question) by passing the approved outcome-neutral criteria, such as absence of floor and ceiling effects or success of positive controls or other quality checks.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2B. Whether the introduction, rationale and stated hypotheses (where applicable) are the same as the approved Stage 1 submission. This can be readily assessed by referring to the </span><a href="{{Stage2vsStage1_trackedchangesURL}}"><strong>tracked-changes manuscript supplied by the authors</strong></a><span style="font-weight: 400;"><a href="{{Stage2vsStage1_trackedchangesURL}}">.</a> </span><span style="font-weight: 400;">{{Stage2_Stage1recommendationtext}}</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2C. Whether the authors adhered precisely to the registered study procedures. For reference, the registered Stage 1 manuscript, unchanged from the point of in-principle acceptance, may be downloaded </span><a href="{{Stage1_registeredURL}}"><strong>here</strong></a><span style="font-weight: 400;">.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2D. Where applicable, whether any unregistered exploratory analyses are justified, methodologically sound, and informative.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2E. Whether the authors’ conclusions are justified given the evidence.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">The PCI RR website includes an</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_6720026472751613309075757"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">expanded description of these review criteria</span></a><span style="font-weight: 400;">, additional</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_7586915642301613635089357"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">tips for reviewing a RR</span></a><span style="font-weight: 400;">, and</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">complete reviewer guidelines</span></a><span style="font-weight: 400;">. To ensure swift handling of submissions, the requested review time is </span><strong>{{reviewDuration}}</strong><span style="font-weight: 400;">, but if you are unable to review the manuscript within this time then please let me know by reply email and we can extend the timeframe.&nbsp;</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Please note that the statistical significance, novelty, or perceived importance of findings will not factor into editorial decisions.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">{{signedreview_invitation_text}}&nbsp;</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">In the event of a favourable outcome, all editorial correspondence (Stage 2 reviews, recommender’s decisions, authors’ replies) and a recommendation text will be published by PCI RR under a CC-BY 4.0 license. If, after one or several rounds of review, the Stage 2 manuscript is rejected, the editorial correspondence (and specifically your Stage 2 review) will NOT be published. You will be notified by e-mail at each stage in the procedure.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">{{programmaticRR_invitation_text}}</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Note that to avoid any conflict of interests, where you know the identity of the submitting authors you should not accept to evaluate this submission if the authors are close colleagues (people belonging to the same laboratory/unit/department in the last four years, people with whom you have published in the last four years, with whom you have received joint funding in the last four years, or with whom you are currently writing a manuscript, or submitting a grant proposal).</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">I would be grateful if you could let me know as soon as possible whether you are willing to accept my invitation to review this article, or whether you would prefer to decline, by clicking on the link below or by logging onto the PCI RR website and going to \'For contributors —&gt; Invitation(s) to review a preprint\' in the top menu. If you are reviewing a revised manuscript, you will find the \authors\' response to reviewers linked on the website.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Many thanks for considering this review request.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Best wishes,</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">{{sender}} and the PCI RR Managing Board</span></div><p>&nbsp;</p>'),
(E'#ReminderReviewInvitationRegisteredUserReturningReviewerStage2',E'default',E'{{appName}}: Invitation to review a Stage 2 submission that you previously reviewed at Stage 1 - reminder',E'Reminder invitation to a registered user who reviewed a Stage 1 manuscript to review the corresponding Stage 2 submission',E'<div><span style="font-weight: 400;">Dear {{destPerson}},</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Thank you for reviewing previously for Peer Community in Registered Reports (PCI RR). This is a kind reminder about the following review invitation.<br></span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Following in-principle acceptance (IPA) of the Stage 1 submission that you reviewed, the authors have submitted a follow-up Stage 2 manuscript entitled "</span><strong>{{art_title}}</strong><span style="font-weight: 400;">". The Stage 2 manuscript contains the content from Stage 1 plus the results and conclusions, and I am writing to ask if you would kindly consider reviewing it for us. A clean version of the Stage 2 manuscript can be viewed and downloaded at the following address: <a href="{{art_doi}}">{{art_doi}}</a>&nbsp;<br></span></div><div>&nbsp;</div><div><span style="font-weight: 400;">{{signedreview_invitation_text}}&nbsp;</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">For reference, the registered Stage 1 manuscript, unchanged from the point of IPA, may be downloaded </span><a title="here" href="{{Stage1_registeredURL}}"><strong>here</strong></a><span style="font-weight: 400;">. To make the review process as easy as possible, a tracked-changes version of the Stage 2 manuscript is also available </span><a title="here" href="{{Stage2vsStage1_trackedchangesURL}}"><strong>here</strong></a><span style="font-weight: 400;"> that shows all text changes between the approved Stage 1 manuscript and the corresponding sections of the Stage 2 manuscript. </span><span style="font-weight: 400;">{{Stage2_Stage1recommendationtext}}</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">{{programmaticRR_invitation_text}}<br></span></div><div>&nbsp;</div><div><span style="font-weight: 400;">In evaluating Stage 2 manuscripts, we ask reviewers to assess:</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2A. Whether the data are able to test the authors’ proposed hypotheses (or answer the proposed research question) by passing the approved outcome-neutral criteria, such as absence of floor and ceiling effects or success of positive controls or other quality checks.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2B. Whether the introduction, rationale and stated hypotheses (where applicable) are the same as the approved Stage 1 submission. This can be readily assessed by referring to the </span><a title="tracked-changes manuscript supplied by the authors" href="{{Stage2vsStage1_trackedchangesURL}}"><strong>tracked-changes manuscript supplied by the authors</strong><span style="font-weight: 400;">.</span></a></div><div>&nbsp;</div><div><span style="font-weight: 400;">2C. Whether the authors adhered precisely to the registered study procedures.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2D. Where applicable, whether any unregistered exploratory analyses are justified, methodologically sound, and informative.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2E. Whether the authors’ conclusions are justified given the evidence.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">The PCI RR website includes an</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_6720026472751613309075757"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">expanded description of these review criteria</span></a><span style="font-weight: 400;">, additional</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_7586915642301613635089357"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">tips for reviewing a RR</span></a><span style="font-weight: 400;">, and</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">complete reviewer guidelines</span></a><span style="font-weight: 400;">. To ensure swift handling of submissions, the requested review time is </span><strong>{{reviewDuration}}</strong><span style="font-weight: 400;">, but if you are unable to review the manuscript within this time then please let me know by reply email and we can extend the timeframe. Where possible, it is important that the same reviewers evaluate submissions at Stage 1 and Stage 2.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Please note that the statistical significance, novelty, or perceived importance of findings will not factor into editorial decisions.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">In the event of a favourable outcome, all editorial correspondence (Stage 2 reviews, recommender’s decisions, authors’ replies) and a recommendation text will be published by PCI RR under a CC-BY 4.0 license. If, after one or several rounds of review, the Stage 2 manuscript is rejected, the editorial correspondence (and specifically your Stage 2 review) will NOT be published. You will be notified by e-mail at each stage in the procedure.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Note that to avoid any conflict of interests, where you know the identity of the submitting authors you should not accept to evaluate this submission if the authors are close colleagues (people belonging to the same laboratory/unit/department in the last four years, people with whom you have published in the last four years, with whom you have received joint funding in the last four years, or with whom you are currently writing a manuscript, or submitting a grant proposal).</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">I would be grateful if you could let me know as soon as possible whether you are willing to accept our invitation to review this article, or whether you would prefer to decline, by clicking on the link below or by logging onto the {{longname}} website and going to \'For contributors —&gt; Invitation(s) to review a report\' in the top menu.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Many thanks for considering this re-review request and for helping to support PCI RR.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Best wishes,</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">{{sender}} and the PCI RR Managing Board</span></div><p>&nbsp;</p>'),
(E'#ReminderReviewerReviewInvitationNewUserStage2',E'default',E'{{appName}}: Invitation to review a Stage 2 manuscript - reminder',E'Reminder invitation to a new user who did NOT review the Stage 1 manuscript to review the corresponding Stage 2 submission',E'<p>Dear <span style="font-weight: 400;">{{destPerson}}</span>,&nbsp;&nbsp;</p><p>This is a kind reminder about the following review invitation.</p><div><span style="font-weight: 400;">A Stage 2 Registered Report entitled "<strong>{{articleTitle}}</strong>", has been submitted for potential recommendation by {{description}} (PCI RR) and I am writing to ask if you would kindly consider reviewing it for us. A clean version of the manuscript can be viewed and downloaded at the following address: <a href="{{art_doi}}" target="_blank" rel="noopener">{{art_doi}}</a></span></div><div>&nbsp;</div><div><span style="font-weight: 400;">As you may know, Registered Reports (RRs) are a form of empirical research article in which manuscripts containing a study proposal are reviewed prior to data collection or analysis. The aim of this initiative is to minimise publication bias and reporting bias, while also allowing the flexibility to conduct exploratory (unregistered) analyses and report serendipitous findings. Submitted manuscripts can propose novel studies or direct replications of previous studies.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">PCI RR is a free, non-commercial platform dedicated to the peer review of RR preprints. Once a preprint is reviewed and positively recommended by PCI RR, authors then have the option to submit their manuscript to a traditional journal, and the reviews are published on the PCI RR website. A growing</span><a href="https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Frr.peercommunityin.org%2Fabout%2Fpci_rr_friendly_journals&amp;data=04%7C01%7Cchambersc1%40cardiff.ac.uk%7C3b0bd2172d19499a650008d934ba39af%7Cbdb74b3095684856bdbf06759778fcbc%7C1%7C0%7C637598796701743675%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=JXBq1vVpf1%2FrbMY0RB9K55orGA%2ByyWDd7mduvA7qQvc%3D&amp;reserved=0"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">list of PCI RR-friendly journals</span></a><span style="font-weight: 400;"> now immediately accept submissions recommended by PCI RR without further peer review.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">The above manuscript previously received Stage 1 in-principle acceptance and is now being considered at Stage 2, which includes the content from Stage 1 plus the results and conclusions. Even though you were not a reviewer at Stage 1, I am writing to ask if you would consider evaluating the Stage 2 manuscript for us.&nbsp;</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">At Stage 2 we ask reviewers to assess:</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2A. Whether the data are able to test the authors’ proposed hypotheses (or answer the proposed research question) by passing the approved outcome-neutral criteria, such as absence of floor and ceiling effects or success of positive controls or other quality checks.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2B. Whether the introduction, rationale and stated hypotheses (where applicable) are the same as the approved Stage 1 submission. This can be readily assessed by referring to the </span><a href="{{Stage2vsStage1_trackedchangesURL}}"><strong>tracked-changes manuscript supplied by the authors</strong><span style="font-weight: 400;">.</span></a>&nbsp;<span style="font-weight: 400;">{{Stage2_Stage1recommendationtext}}</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2C. Whether the authors adhered precisely to the registered study procedures. For reference, the registered Stage 1 manuscript, unchanged from the point of in-principle acceptance, may be downloaded </span><a href="{{Stage1_registeredURL}}"><strong>here</strong><span style="font-weight: 400;">.</span></a></div><div>&nbsp;</div><div><span style="font-weight: 400;">2D. Where applicable, whether any unregistered exploratory analyses are justified, methodologically sound, and informative.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">2E. Whether the authors’ conclusions are justified given the evidence.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">The PCI RR website includes an</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_6720026472751613309075757"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">expanded description of these review criteria</span></a><span style="font-weight: 400;">, additional</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers#h_7586915642301613635089357"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">tips for reviewing a RR</span></a><span style="font-weight: 400;">, and</span><a href="https://rr.peercommunityin.org/help/guide_for_reviewers"><span style="font-weight: 400;"> </span><span style="font-weight: 400;">complete reviewer guidelines</span></a><span style="font-weight: 400;">. To ensure swift handling of submissions, the requested review time is </span><strong>{{reviewDuration}}</strong><span style="font-weight: 400;">, but if you are unable to review the manuscript within this time then please let me know by reply email and we can extend the timeframe.&nbsp;</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Please note that the statistical significance, novelty, or perceived importance of findings will not factor into editorial decisions.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">{{signedreview_invitation_text}}&nbsp;</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">In the event of a favourable outcome, all editorial correspondence (Stage 2 reviews, recommender’s decisions, authors’ replies) and a recommendation text will be published by PCI RR under a CC-BY 4.0 license. If, after one or several rounds of review, the Stage 2 manuscript is rejected, the editorial correspondence (and specifically your Stage 2 review) will NOT be published. You will be notified by e-mail at each stage in the procedure.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">{{programmaticRR_invitation_text}}</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Note that to avoid any conflict of interests, where you know the identity of the submitting authors you should not accept to evaluate this submission if the authors are close colleagues (people belonging to the same laboratory/unit/department in the last four years, people with whom you have published in the last four years, with whom you have received joint funding in the last four years, or with whom you are currently writing a manuscript, or submitting a grant proposal).</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">I would be most grateful if you could let me know using the link below whether you are willing to accept our invitation to review this article, or whether you would prefer to decline. If you accept the assignment then once you have entered a new password and logged onto the website, please go to \'For contributors —&gt; Invitation(s) to review a report\' in the top menu. If you are reviewing a revised manuscript, you will find the \authors\' response to reviewers linked on the website.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Many thanks for considering this review request.</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">Best wishes,</span></div><div>&nbsp;</div><div><span style="font-weight: 400;">{{sender}} and the PCI RR Managing Board</span></div><p>&nbsp;</p>');
